BJDX - Company ID 0001704287
The table below shows Bluejay Diagnostics, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$6.05M | -$7.82M | -$8.31M | -$7.74M | -$4.37M | -$508.71K |
| Capital expenditure | $173.74K | $306.78K | $704.17K | $1.20M | $23.95K | - |
| Investing cash flow | -$173.74K | -$306.78K | -$704.17K | -$1.20M | -$23.95K | - |
| Dividends paid | - | - | - | - |
Bluejay Diagnostics, Inc. reported operating cash flow of -$6.05M for fiscal year 2025. That is up 22.6% from -$7.82M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$508.71K (FY 2020) to -$6.05M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $7.09M | $10.22M | $1.11M | $8.07K | $22.53M | $1.33M |